Advice

Following a full submission:

budesonide gastro-resistant capsule (Budenofalk®) is accepted for use within NHS Scotland.

Indication under review: symptomatic relief of chronic diarrhoea due to collagenous colitis.

budesonide (Budenofalk®) provides symptomatic improvement of diarrhoea associated with collagenous colitis compared with placebo.

Download detailed advice122KB (PDF)

Download

Medicine details

Medicine name:
budesonide 3mg gastro-resistant capsule (Budenofalk)
SMC ID:
828/12
Indication:
For the symptomatic relief of chronic diarrhoea due to collagenous colitis.
Pharmaceutical company
Dr Falk Pharma UK
BNF chapter
Gastro-intestinal system
Submission type
Full
Status
Accepted
Date advice published
14 January 2013